NYSE
-$0.47
(-0.38%)
Subscribe to get
AI Score
On Thursday, Eli Lilly (NYSE:LLY) announced a substantial $3 billion investment to expand its recently acquired manufacturing facility in Pleasant Prairie, Wisconsin. The expansion aims to increase ...
The Indianapolis-based company (NYSE: LLY) announced Thursday it plans to start the expansion...
Eli Lilly (NYSE:LLY) has been making headlines recently with its weight-loss drug Zepbound...
Eli Lilly (LLY) announced that its weight-loss drug, Zepbound, demonstrated superior results in a head-to-head trial against Novo Nordisk's (NVO) Wegovy. Partic
Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in...
Eli Lilly and Company LLY announced that its popular obesity drug, Zepbound (tirzepatide)...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke...
Eli Lilly (LLY) announced topline results from the SURMOUNT-5 phase 3b open-label randomized...
The two market-leading weight loss/obesity drugs (GLP-1), Zepabound (Eli Lilly (NYSE:LLY)) and...
It wouldn't be wrong to at least explore one of only a handful of names this ultrarich crowd can...